Zurich Cantonal Bank’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $557K | Buy |
10,073
+981
| +11% | +$54.2K | ﹤0.01% | 1588 |
|
|
2025
Q1 | $440K | Sell |
9,092
-610
| -6% | -$29.5K | ﹤0.01% | 1676 |
|
|
2024
Q4 | $374K | Sell |
9,702
-126
| -1% | -$4.86K | ﹤0.01% | 1802 |
|
|
2024
Q3 | $442K | Sell |
9,828
-16
| -0.2% | -$720 | ﹤0.01% | 1634 |
|
|
2024
Q2 | $341K | Sell |
9,844
-19
| -0.2% | -$658 | ﹤0.01% | 1757 |
|
|
2024
Q1 | $285K | Sell |
9,863
-475
| -5% | -$13.7K | ﹤0.01% | 1842 |
|
|
2023
Q4 | $237K | Buy |
10,338
+1,093
| +12% | +$25.1K | ﹤0.01% | 1987 |
|
|
2023
Q3 | $154K | Sell |
9,245
-465
| -5% | -$7.76K | ﹤0.01% | 2129 |
|
|
2023
Q2 | $268K | Sell |
9,710
-450
| -4% | -$12.4K | ﹤0.01% | 1725 |
|
|
2023
Q1 | $234K | Buy |
10,160
+1,624
| +19% | +$37.4K | ﹤0.01% | 1774 |
|
|
2022
Q4 | $93.1K | Buy |
8,536
+1,337
| +19% | +$14.6K | ﹤0.01% | 2317 |
|
|
2022
Q3 | $61K | Hold |
7,199
| – | – | ﹤0.01% | 2521 |
|
|
2022
Q2 | $57K | Hold |
7,199
| – | – | ﹤0.01% | 2537 |
|
|
2022
Q1 | $170K | Buy |
7,199
+906
| +14% | +$21.4K | ﹤0.01% | 1992 |
|
|
2021
Q4 | $215K | Buy |
6,293
+3,864
| +159% | +$132K | ﹤0.01% | 2020 |
|
|
2021
Q3 | $43K | Buy |
+2,429
| New | +$43K | ﹤0.01% | 2656 |
|